BRG Borregaard

Borregaard ASA: New CEO reinforces Borregaard’s commitment to specialisation and value growth

Borregaard ASA: New CEO reinforces Borregaard’s commitment to specialisation and value growth

Tom Erik Foss-Jacobsen assumed his position as Borregaard’s new CEO on 1 August (see notice to Oslo Stock Exchange 23 May 2025).

“Borregaard is well positioned with six production units, three R&D centres, and thirteen sales offices in key markets across Europe, the Americas, and Asia. We will continue to build on this solid foundation and our highly skilled organisation to advance our strategy of specialisation and value growth. Borregaard will continue to build on a strong legacy of specialisation and value growth. With a deep understanding of our organisation, operations, and strategic priorities, I am confident in our collective ability to continue driving sustainable growth and delivering long-term value for Borregaard and its stakeholders," says CEO Tom Erik Foss-Jacobsen.

Changes in Borregaard’s Group Executive Management:

Knut-Harald Bakke has been appointed Executive Vice President of the BioSolutions business area. (See notice to Oslo Stock Exchange 13 June 2025). Bakke previously served as Director of Investor Relations and earlier held the position of Energy Director at Borregaard.

Kari Strande has been appointed Senior Vice President, Human Resources with responsibility for people and organisational development. Strande previously served as Head of the HR Department.

Dag Arthur Aasbø will continue as part of the Group Executive Management as Senior Vice President, Public Affairs and Sustainability. He will continue in his role within public affairs and will also assume overall responsibility for sustainability.

Ole Gunnar Jakobsen will continue as part of the Group Executive Management as Executive Vice President, Manufacturing and Technology with overall global responsibility for manufacturing and technology across Borregaard’s production units. Jakobsen previously served as Plant Director for the biorefinery in Sarpsborg.

For more information about the Group Executive Management Team effective from 1 August, please see .

Contact:

Per Bjarne Lyngstad, CFO,

This information is subject to the disclosure requirements pursuant to Section 5-12 of the Norwegian Securities Trading Act.





EN
01/08/2025

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Borregaard

 PRESS RELEASE

Borregaard ASA: Issuance of Commercial Paper

Borregaard ASA: Issuance of Commercial Paper Borregaard ASA has issued a commercial paper ISIN NO0013708651 of NOK 100,000,000. Start date: 12 December, 2025Maturity: 12 February, 2026Coupon: 4,43 %Organised by: DNB Carnegie Sarpsborg, 10 December 2025 Contact:CFO, Per Bjarne Lyngstad, +47 952 44 515 This information is subject to the disclosure requirements pursuant to Section 5 -12 of the Norwegian Securities Trading Act.  

ABGSC Pulp & Paper Research ... (+3)
  • ABGSC Pulp & Paper Research
  • Henrik Bartnes
  • Martin Melbye
ABGSC Pulp & Paper Research ... (+3)
  • ABGSC Pulp & Paper Research
  • Henrik Bartnes
  • Martin Melbye
 PRESS RELEASE

Borregaard ASA: EBITDA1 of NOK 440 million in the 3rd quarter

Borregaard ASA: EBITDA1 of NOK 440 million in the 3rd quarter Borregaard’s operating revenues were NOK 1,799 million (NOK 1,949 million)2 in the 3rd quarter of 2025. EBITDA1 was NOK 440 million (NOK 524 million). The result in BioSolutions increased while BioMaterials and Fine Chemicals had lower results compared with the 3rd quarter of 2024. The reduced EBITDA1 was due to lower bioethanol prices and the temporary disruption in cellulose production at the Sarpsborg site. The negative impact from this disruption amounts to approximately NOK 40 million. The improvement in the result for BioS...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch